glutaral has been researched along with thalidomide in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Albert, M; Corral, LG; Haslett, PA; Kaplan, G | 1 |
2 other study(ies) available for glutaral and thalidomide
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset.
Topics: Antibodies, Monoclonal; Antigen-Presenting Cells; CD3 Complex; CD8-Positive T-Lymphocytes; Cell Division; Cells, Cultured; Cytokines; Cytotoxicity Tests, Immunologic; Dendritic Cells; Enterotoxins; Fixatives; Glutaral; Humans; Mitogens; Superantigens; Thalidomide | 1998 |